Philip Morris seen landing IQOS risk claim despite setback

Jan. 25, 2018 12:56 PM ETPhilip Morris International Inc. (PM)PMBy: Clark Schultz, SA News Editor27 Comments
  • Height Securities analyst Stefanie Miller thinks Philip Morris International (PM -2.2%) is likely to end up with FDA approval for its IQOS risk claim.
  • Miller says the advisory committee that ruled today was too "unprepared" and "inexperienced" to do anything but act as a roadblock. She also points out that the panel's recommendation is non-binding.
  • Philip Morris is looking for the modified risk tobacco product designation from the agency to help market IQOS products.
  • Previously: FDA rejects Philip Morris IQOS claims (Jan. 25)
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.